- Home
- FCF vs ARWR Comparison
FCF vs ARWR Comparison
Compare FCF & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCF
- ARWR
- Stock Information
- Founded
- FCF 1934
- ARWR 2003
- Country
- FCF United States
- ARWR United States
- Employees
- FCF N/A
- ARWR N/A
- Industry
- FCF Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- FCF Finance
- ARWR Health Care
- Exchange
- FCF Nasdaq
- ARWR Nasdaq
- Market Cap
- FCF 1.6B
- ARWR 1.8B
- IPO Year
- FCF N/A
- ARWR 1993
- Fundamental
- Price
- FCF $15.60
- ARWR $16.07
- Analyst Decision
- FCF Buy
- ARWR Buy
- Analyst Count
- FCF 8
- ARWR 10
- Target Price
- FCF $18.94
- ARWR $42.13
- AVG Volume (30 Days)
- FCF 489.9K
- ARWR 1.9M
- Earning Date
- FCF 07-22-2025
- ARWR 05-12-2025
- Dividend Yield
- FCF 3.46%
- ARWR N/A
- EPS Growth
- FCF N/A
- ARWR N/A
- EPS
- FCF 1.34
- ARWR N/A
- Revenue
- FCF $448,664,000.00
- ARWR $545,209,000.00
- Revenue This Year
- FCF $14.21
- ARWR $4,380.43
- Revenue Next Year
- FCF $7.73
- ARWR $66.56
- P/E Ratio
- FCF $11.66
- ARWR N/A
- Revenue Growth
- FCF N/A
- ARWR 1436.97
- 52 Week Low
- FCF $12.71
- ARWR $9.57
- 52 Week High
- FCF $19.96
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- FCF 49.48
- ARWR 59.58
- Support Level
- FCF $15.49
- ARWR $14.92
- Resistance Level
- FCF $15.83
- ARWR $17.19
- Average True Range (ATR)
- FCF 0.26
- ARWR 0.95
- MACD
- FCF -0.06
- ARWR 0.11
- Stochastic Oscillator
- FCF 35.25
- ARWR 70.29
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.